Werkgroep Cardiologische centra Nederland English

PARADISE-MI (Includerend)

A multi-center, randomized, double-blind, active-controlled, parallel-group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to Ramipril in acute MI patients with evidence of LV dysfunction (but without prior history of chronic HF)

Middel
LCZ696
Populatie
acuut coronair syndroom
Fase
III
Jaar aanvang
2016
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr M.E. Emans (Cardioloog)
Rotterdam, Ikazia Ziekenhuis